Third phase of Covaxin’s clinical trials begins at research institute

Based on the results of the trial, vaccine may be licensed commercially in early 2021, says MGMCRI

from The Hindu - Home https://ift.tt/2WG8iAS
https://ift.tt/2IyLjhI